Details of Drug

Drug General Information (ID: D0242)
Drug Name	Calcium glycerophosphate
Drug Type	Small molecule
Drug Synonymous	calcium glycerophosphate; 27214-00-2; calcium 2,3-dihydroxypropyl phosphate; 1336-00-1; Calcium glycerol phosphate; Calcium 1-glycerophosphate; 126-95-4; calcium;2,3-dihydroxypropyl phosphate; Glycerol phosphate calcium salt hydrate; 1,2,3-Propanetriol, mono(dihydrogen phosphate), calcium salt (1:1); MFCD00151656; CALCIUM GLYCERINOPHOSPHATE; 2,3-Dihydroxypropyl (dihydrogen phosphate), calcium salt; Calcium 2,3-hydroxypropyl phosphate; EINECS 204-813-3; EINECS 215-643-4; MFCD00042643; Calcii glycerophosphas; 1,2,3-Propanetriol, 1-(dihydrogen phosphate), calcium salt (1:1); C3H7CaO6P; SCHEMBL4237; CHEMBL2106124; DTXSID40873179; CS-B1784; HY-B2203; EINECS 249-312-0; AKOS015962876; AC-2077; P752; FT-0700768; FT-0775133; J-006411; J-017324; Q27286832; 4-AMINO-ALPHA-DIETHYLAMINO-O-CRESOLDIHYDROCHLORIDE Click to Show/Hide
Therapeutic Class	Minerals And Electrolytes
Structure
Structure	3D Structure		2D Structure
Formula	C3H7CaO6P
InChI	InChI=1S/C3H9O6P.Ca/c4-1-3(5)2-9-10(6,7)8;/h3-5H,1-2H2,(H2,6,7,8);/q;+2/p-2
InChIKey	IWIRHXNCFWGFJE-UHFFFAOYSA-L
Canonical SMILES	C(C(COP(=O)([O-])[O-])O)O.[Ca+2]
External Link
External Link	Pubchem ID	120096

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM089 Antagonize the effect of antihypertensive agents BM107 Attenuated pharmacological effects (Unspecific) BM108 Increased risk of hypercalcemia BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Calcium glycerophosphate
Affected gastrointestinal absorption
	Complex formation					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0181		Bictegravir	C21H18F3N3O5	90311989	Major		Inter Info	[1], [2], [3]
D0515		Dolutegravir	C20H19F2N3O5	54726191	Major		Inter Info	[6]
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[7], [8], [9]
D0144		Baloxavir marboxil	C27H23F2N3O7S	124081896	Moderate		Inter Info	[15]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D0433		Deferiprone	C7H9NO2	2972	Moderate		Inter Info	[51]
D0561		Eltrombopag	C25H22N4O4	135449332	Moderate		Inter Info	[2], [52]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[8], [53], [9]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[29], [30], [43]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[29], [30], [43]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]
D1245		Penicillamine	C5H11NO2S	5852	Moderate		Inter Info	[54], [55], [56], [57], [58], [59], [60], [37]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[7], [8], [9]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Moderate		Inter Info	[29], [30], [43]
Pharmacodynamic additive effects
	Increased risk of hypercalcemia					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1753		Calcipotriol (topical)	C27H40O3	5288783	Moderate		Inter Info	[13], [14]
D1754		Calcitriol (topical)	C27H44O3	5280453	Moderate		Inter Info	[13], [14]
D0321		Chlorothiazide	C7H6ClN3O4S2	2720	Moderate		Inter Info	[48], [49], [50]
D0326		Chlorthalidone	C14H11ClN2O4S	2732	Moderate		Inter Info	[48], [49], [50]
D0771		Hydrochlorothiazide	C7H8ClN3O4S2	3639	Moderate		Inter Info	[48], [49], [50]
D0775		Hydroflumethiazide	C8H8F3N3O4S2	3647	Moderate		Inter Info	[48], [49], [50]
D0798		Indapamide	C16H16ClN3O3S	3702	Moderate		Inter Info	[48], [49], [50]
D1048		Metolazone	C16H16ClN3O3S	4170	Moderate		Inter Info	[48], [49], [50]
D1311		Polythiazide	C11H13ClF3N3O4S3	4870	Moderate		Inter Info	[48], [49], [50]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0221		Burosumab	NA	NA	Major		Inter Info	[4]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[10], [11], [12]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[10], [11], [12]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[10], [11], [12]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[10], [11], [12]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[10], [11], [12]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[10], [11], [12]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[10], [11], [12]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[10], [11], [12]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[10], [11], [12]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[10], [11], [12]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0590		Erdafitinib	C25H30N6O2	67462786	Major		Inter Info	[5]

References
1	Cerner Multum, Inc. "Australian Product Information.".
2	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3	Product Information. Biktarvy (bictegravir/emtricitabine/tenofovir). Gilead Sciences, Foster City, CA.
4	Product Information. Crysvita (burosumab). Ultragenyx Pharmaceutical, Novato, CA.
5	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
6	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
7	Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
8	Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
9	Product Information. Skelid (tilundronate). Sanofi Winthrop Pharmaceuticals, New York, NY.
10	Woie L, Storstein L "Successful treatment of suicidal verapamil poisoning with calcium gluconate." Eur Heart J 2 (1981): 239-42
11	Oszko MA, Klutman NE "Use of calcium salts during cardiopulmonary resuscitation for reversing verapamil-associated hypotension." Clin Pharm 6 (1987): 448-9
12	Lipman J, Jardine I, Roos C, Dreosti L "Intravenous calcium chloride as an antidote to verapamil-induced hypotension." Intensive Care Med 8 (1982): 55-7
13	Product Information. Vectical (calcitriol topical). Galderma Laboratories Inc, Cranbury, NJ.
14	Product Information. Dovonex (calcipotriene). Westwood Squibb Pharmaceutical Corporation, Eatontown, NJ.
15	Product Information. Xofluza (baloxavir marboxil). Genentech, South San Francisco, CA.
16	Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
17	Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
18	Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
19	Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
20	Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
21	Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
22	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
23	Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
24	Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
25	Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
26	Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
27	Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
28	Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
29	Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
30	Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
31	Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
32	Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
33	Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
34	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
35	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
36	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
37	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
38	Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
39	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
40	Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
41	Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
42	Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
43	Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
44	Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
45	Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
46	Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
47	Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
48	Santos F, Smith MJ, Chan JC "Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide." Am J Dis Child 140 (1986): 139-42
49	Drinka PJ, Nolten WE "Hazards of treating osteoporosis and hypertension concurrently with calcium, vitamin D, and distal diuretics." J Am Geriatr Soc 32 (1984): 405-7
50	Duarte CG, Winnacker JL, Becker KL, Pace A "Thiazide-induced hypercalcemia." N Engl J Med 284 (1971): 828-30
51	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
52	Product Information. Promacta (eltrombopag). GlaxoSmithKline, Research Triangle Park, NC.
53	Product Information. Fosamax (alendronate). Merck &amp Co, Inc, West Point, PA.
54	Haagsma CJ "Clinically important drug interactions with disease-modifying antirheumatic drugs." Drugs Aging 13 (1998): 281-9. [PMID: 9805209]
55	Harkness JA, Blake DR "Penicillamine nephropathy and iron." Lancet 2 (1982): 1368-9. [PMID: 6129465]
56	Joyce DA "D-penicillamine pharmacokinetics and pharmacodynamics in man." Pharmacol Ther 42 (1989): 405-27. [PMID: 2672052]
57	Lyle WH "Penicillamine and iron." Lancet 2 (1976): 420. [PMID: 73880]
58	Netter P, Bannwarth B, Pere P, Nicolas A "Clinical pharmacokinetics of D-penicillamine." Clin Pharmacokinet 13 (1987): 317-33. [PMID: 3319347]
59	Osman MA, Patel RB, Schuna A, Sundstrom WR, Welling PG "Reduction in oral penicillamine absorption by food, antacid and ferrous sulfate." Clin Pharmacol Ther 33 (1983): 465-70. [PMID: 6831825]
60	Product Information. Cuprimine (penicillamine). Merck & Co, Inc, West Point, PA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence